Crossref

1. Postprandial Peaking and Plateauing of Triglycerides and VLDL in Patients with Underlying Cardiovascular Diseases Despite Treatment

- Clarissa E. Samson

- Ana Lyza B. Galia

- Khristine Ivy C. Llave

- Manuel B. Zacarias

- Leilani B. Mercado-Asis

2. Efficacy of orlistat in non‑alcoholic fatty liver disease: A systematic review and meta‑analysis

- Hu Wang

- Li Wang

- Yujia Cheng

- Zhiqing Xia

- Yifeng Liao

- Jiang Cao

3. Effects of oral contraceptives plus orlistat in patients with polycystic ovary syndrome and overweight/obesity: A meta‐analysis

- Zhangming Chen

- Zhaowei Cai

4. Benefit-Risk Assessment of Orlistat in the Treatment of Obesity

- Priya Sumithran

- Joseph Proietto

5.

6. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

- Genovefa D. Kolovou

- Gerald F. Watts

- Dimitri P. Mikhailidis

- Pablo Pérez-Martínez

- Samia Mora

- Helen Bilianou

- George Panotopoulos

- Niki Katsiki

- Teik C. Ooi

- José Lopez-Miranda

- Anne Tybjærg-Hansen

- Nicholas Tentolouris

- Børge G. Nordestgaard

7. Postprandial Metabolic Responses to High-fat Feeding in Healthy Adults Following Ingestion of Oolong Tea–Derived Polymerized Polyphenols: A Randomized, Double-blinded, Placebo-controlled Crossover Study

- Oliver J. Perkin

- Yung-Chih Chen

- Drusus A. Johnson

- Joel E. Thomas

- Greg Atkinson

- James A. Betts

- Javier T. Gonzalez

8. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance

- Jinghua Song

- Xiangyan Ruan

- Muqing Gu

- Lijuan Wang

- Husheng Wang

- Alfred Otto Mueck

9. Potential Drug Combinations to Reduce Cardiovascular Disease Burden in Diabetes

- Sivaram Pillarisetti